S100A4 protein may be immunotherapy target for glioblastomas (IMAGE)
Caption
Immune cells positive for a protein, S100A4 (arrows) could be a potential therapeutic target for restoring antitumor action of immune cells toward glioblastomas.
Credit
Houston Methodist
Usage Restrictions
None.
License
Original content